179 related articles for article (PubMed ID: 21243428)
1. Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells.
Ali-Rahmani F; Hengst JA; Connor JR; Schengrund CL
Neurochem Res; 2011 Sep; 36(9):1687-96. PubMed ID: 21243428
[TBL] [Abstract][Full Text] [Related]
2. C282Y-HFE gene variant affects cholesterol metabolism in human neuroblastoma cells.
Ali-Rahmani F; Huang MA; Schengrund CL; Connor JR; Lee SY
PLoS One; 2014; 9(2):e88724. PubMed ID: 24533143
[TBL] [Abstract][Full Text] [Related]
3. Expression of the HFE allelic variant H63D in SH-SY5Y cells affects tau phosphorylation at serine residues.
Hall EC; Lee SY; Mairuae N; Simmons Z; Connor JR
Neurobiol Aging; 2011 Aug; 32(8):1409-19. PubMed ID: 19775775
[TBL] [Abstract][Full Text] [Related]
4. The effects of okra (Abelmoschus esculentus Linn.) on the cellular events associated with Alzheimer's disease in a stably expressed HFE neuroblastoma SH-SY5Y cell line.
Mairuae N; Connor JR; Lee SY; Cheepsunthorn P; Tongjaroenbuangam W
Neurosci Lett; 2015 Aug; 603():6-11. PubMed ID: 26170247
[TBL] [Abstract][Full Text] [Related]
5. Prolyl-peptidyl isomerase, Pin1, phosphorylation is compromised in association with the expression of the HFE polymorphic allele, H63D.
Hall EC; Lee SY; Simmons Z; Neely EB; Nandar W; Connor JR
Biochim Biophys Acta; 2010 Apr; 1802(4):389-95. PubMed ID: 20060900
[TBL] [Abstract][Full Text] [Related]
6. H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment.
Ali-Rahmani F; Grigson PS; Lee S; Neely E; Connor JR; Schengrund CL
Neurobiol Aging; 2014 Jun; 35(6):1511.e1-12. PubMed ID: 24439478
[TBL] [Abstract][Full Text] [Related]
7. The H63D HFE gene variant promotes activation of the intrinsic apoptotic pathway via mitochondria dysfunction following β-amyloid peptide exposure.
Mairuae N; Hall Ii EC; Cheepsunthorn P; Lee SY; Connor JR
J Neurosci Res; 2010 Nov; 88(14):3079-89. PubMed ID: 20734416
[TBL] [Abstract][Full Text] [Related]
8. Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1.
Mitchell RM; Lee SY; Randazzo WT; Simmons Z; Connor JR
J Neuroinflammation; 2009 Feb; 6():6. PubMed ID: 19228389
[TBL] [Abstract][Full Text] [Related]
9. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE.
Lee SY; Patton SM; Henderson RJ; Connor JR
FASEB J; 2007 Feb; 21(2):564-76. PubMed ID: 17194693
[TBL] [Abstract][Full Text] [Related]
10. Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload.
Cançado RD; Guglielmi AC; Vergueiro CS; Rolim EG; Figueiredo MS; Chiattone CS
Sao Paulo Med J; 2006 Mar; 124(2):55-60. PubMed ID: 16878186
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
[TBL] [Abstract][Full Text] [Related]
12. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample.
Vizzi E; Loureiro CL; Gerder M; de las Nieves Garcia-Casal M; Rodríguez-Larralde A; Gerace L; Ludert JE; Liprandi F; Pujol FH
Ann Hematol; 2005 Nov; 84(12):802-6. PubMed ID: 15995871
[TBL] [Abstract][Full Text] [Related]
14. Frequency of the hemochromatosis gene (HFE) variants in a Jordanian Arab population and in diabetics from the same region.
Alkhateeb A; Uzrail A; Bodoor K
Dis Markers; 2009; 27(1):17-22. PubMed ID: 19822954
[TBL] [Abstract][Full Text] [Related]
15. [ALLELES C282Y AND H63D HFE GENE, INSULIN RESISTANCE AND SUSCEPTIBILITY TO DISTURBANCE OF PORPHYRIN METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE].
Krivosheev AB; Maximov VN; Voevoda MI; Kuimov AD; Kondratova MA; Tuguleva TA; Koval ON; Bezrukova AA; Bogorianova PA; Rybina OV
Eksp Klin Gastroenterol; 2015; (3):39-44. PubMed ID: 26281176
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HFE in HepG2 cells reveals differences in intracellular distribution and co-localization of wt- and mutated forms.
Pinto JP; Ramos P; de Sousa M
Blood Cells Mol Dis; 2007; 39(1):75-81. PubMed ID: 17428702
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hemochromatosis gene (HFE) mutations in Greece.
Papazoglou D; Exiara T; Speletas M; Panagopoulos I; Maltezos E
Acta Haematol; 2003; 109(3):137-40. PubMed ID: 12714823
[TBL] [Abstract][Full Text] [Related]
18. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
Aranda N; Viteri FE; Montserrat C; Arija V
Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.
Cukjati M; Vaupotic T; Rupreht R; Curin-Serbec V
BMC Med Genet; 2007 Nov; 8():69. PubMed ID: 18036208
[TBL] [Abstract][Full Text] [Related]
20. Association of HFE mutations (C282Y and H63D) with iron overload in blood donors from Mexico City.
Baptista-González HA; Rosenfeld-Mann F; Trueba-Gómez R; Bermejo-Martínez L; Méndez-Sánchez N
Ann Hepatol; 2007; 6(1):55-60. PubMed ID: 17297430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
